Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Acorda Therapeutics (ACOR) News Today

Acorda Therapeutics logo

ACOR Latest News

Acorda: I did not accept money from Guo
Acorda Therapeutics Announces Delisting from Nasdaq
Acorda Therapeutics Inc.
Why Acorda Therapeutics Stock Is Down Nearly 90%
Acorda Therapeutics (Nasdaq:ACOR) Headline
Trading was temporarily halted for "ACOR" at 11:04 AM with a stated reason of "LULD pause."...
Acorda Therapeutics (Nasdaq:ACOR) Headline
Trading was temporarily halted for "ACOR" at 11:04 AM with a stated reason of "LULD pause."...
Acorda Therapeutics (Nasdaq:ACOR) Headline
Trading was temporarily halted for "ACOR" at 10:04 AM with a stated reason of "LULD pause."...
Acorda Therapeutics (Nasdaq:ACOR) Headline
Trading was temporarily halted for "ACOR" at 10:04 AM with a stated reason of "LULD pause."...
Acorda Therapeutics (Nasdaq:ACOR) Headline
Trading was temporarily halted for "ACOR" at 10:04 AM with a stated reason of "LULD pause."...
Why Is Acorda Therapeutics (ACOR) Stock Down 72% Today?
Retired PNP chief Acorda: I did my best
Stocks to Watch: PVH, Canoo, Acorda Therapeutics
3 Biotech Stocks to Watch in March for Success
Acorda: No policy vs. TikTok use in PNP
Acorda Therapeutics To Regain Worldwide Commercialization Rights To FAMPYRA
3 Biotech Stocks to Keep an Eye on in 2024
Acorda eyes Pinoy apps vs cybercrimes
Acorda Therapeutics Inc ACOR
Get Acorda Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACOR and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ACOR Media Mentions By Week

ACOR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACOR
News Sentiment

0.00

0.94

Average
Medical
News Sentiment

ACOR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACOR Articles
This Week

0

0

ACOR Articles
Average Week

Get the Latest News and Ratings for ACOR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Acorda Therapeutics and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:ACOR) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners